|
US8295A
(en)
|
|
1851-08-12 |
|
Construction- of roofs |
|
SU1138164A1
(ru)
|
1963-04-25 |
1985-02-07 |
Shadurskij Konstantin S |
Антигистаминное средство "димебон
|
|
US4407957A
(en)
|
1981-03-13 |
1983-10-04 |
Damon Corporation |
Reversible microencapsulation of a core material
|
|
FI844786A0
(fi)
|
1984-12-04 |
1984-12-04 |
Farmos Oy |
Terapeutiskt utnyttjbar foerening.
|
|
US4839170A
(en)
|
1985-10-01 |
1989-06-13 |
Survival Technology, Inc. |
Protein absorption enhancing agents
|
|
US4767789A
(en)
|
1986-10-21 |
1988-08-30 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
|
US4760094A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
|
US4760093A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
|
US5039540A
(en)
|
1989-08-14 |
1991-08-13 |
Neophore Technologies, Inc. |
Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
|
|
US5217718A
(en)
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
|
US5178878A
(en)
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5215756A
(en)
|
1989-12-22 |
1993-06-01 |
Gole Dilip J |
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
|
US5188825A
(en)
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
|
CA2109085C
(en)
|
1991-04-25 |
2003-03-11 |
Keith E. Dionne |
Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
|
|
US5352456A
(en)
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
ES2179831T3
(es)
|
1992-09-29 |
2003-02-01 |
Inhale Therapeutic Syst |
Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
|
|
US5343672A
(en)
|
1992-12-01 |
1994-09-06 |
Scherer Ltd R P |
Method for manufacturing freeze dried dosages in a multilaminate blister pack
|
|
US5631023A
(en)
|
1993-07-09 |
1997-05-20 |
R.P. Scherer Corporation |
Method for making freeze dried drug dosage forms
|
|
GB2281206A
(en)
|
1993-08-25 |
1995-03-01 |
Orion Yhtymae Oy |
Use of dexmedetomidine
|
|
US5457895A
(en)
|
1993-10-01 |
1995-10-17 |
R. P. Scherer Corporation |
Method of identifying freeze-dried dosage forms
|
|
US5508367A
(en)
|
1993-11-29 |
1996-04-16 |
Adhesives Research, Inc. |
Water-soluble pressure sensitive adhesive
|
|
CA2154483C
(en)
|
1993-11-29 |
2001-03-27 |
Michael J. Zajaczkowski |
Water-soluble pressure sensitive adhesive
|
|
US5395907A
(en)
|
1993-11-29 |
1995-03-07 |
Adhesive Research, Inc. |
Water-soluble pressure sensitive adhesive
|
|
FR2718357B1
(fr)
|
1994-04-06 |
1997-10-03 |
Defarges Alain Moreau |
Perfectionnements apportés à un dispositif d'injection par jet sans aiguille.
|
|
GB2290964A
(en)
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
|
US5731387A
(en)
|
1994-07-11 |
1998-03-24 |
Adhesives Research, Inc. |
Ionically-crosslinked water-absorbent graft copolymer
|
|
US5726250A
(en)
|
1994-07-11 |
1998-03-10 |
Adhesives Research, Inc. |
Covalently crosslinked water-absorbent graft copolymer
|
|
GB9421836D0
(en)
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
|
US5837287A
(en)
|
1994-10-28 |
1998-11-17 |
R P Scherer Corporation |
Process for preparing solid pharmaceutical dosage forms
|
|
US6726928B2
(en)
|
1994-10-28 |
2004-04-27 |
R.P. Scherer Technologies, Inc. |
Process for preparing solid dosage forms for unpalatable pharmaceuticals
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5605911A
(en)
|
1995-01-31 |
1997-02-25 |
Washington University |
Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
|
|
US5700873A
(en)
|
1995-03-07 |
1997-12-23 |
Adhesives Research, Inc. |
Method of preparation of water-soluble copolymer
|
|
US5780014A
(en)
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
|
US5654007A
(en)
|
1995-06-07 |
1997-08-05 |
Inhale Therapeutic Systems |
Methods and system for processing dispersible fine powders
|
|
GB9616672D0
(en)
|
1996-08-08 |
1996-09-25 |
Scherer Ltd R P |
Pharmaceutical compositions
|
|
US5800832A
(en)
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
|
GB9702799D0
(en)
|
1997-02-12 |
1997-04-02 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms
|
|
AU736912B2
(en)
|
1997-02-20 |
2001-08-02 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
|
US6239228B1
(en)
|
1997-02-21 |
2001-05-29 |
Adhesives Research, Inc. |
Pressure sensitive adhesive containing macromer having repeat hydrophilic moieties
|
|
US5951999A
(en)
|
1997-02-21 |
1999-09-14 |
Adhesives Research, Inc. |
Transdermal pressure sensitive adhesive drug delivery system
|
|
CA2276339A1
(en)
|
1997-02-21 |
1998-08-27 |
Michael J. Zajaczkowski |
Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
|
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
US5976577A
(en)
|
1997-07-11 |
1999-11-02 |
Rp Scherer Corporation |
Process for preparing fast dispersing solid oral dosage form
|
|
DE69834255T2
(de)
|
1997-07-25 |
2006-09-28 |
Alpex Pharma S.A. |
Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
|
|
US7632517B2
(en)
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
|
GB9802088D0
(en)
|
1998-01-30 |
1998-03-25 |
Scherer Ltd R P |
Pharmaceutical products
|
|
EP1107911B1
(en)
|
1998-03-09 |
2005-01-19 |
Cima Labs Inc. |
Apparatus for handling and packaging friable tablets
|
|
US6200604B1
(en)
|
1998-03-27 |
2001-03-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
US6716867B1
(en)
|
1998-04-01 |
2004-04-06 |
Orion Corporation |
Use of dexmedetomidine for ICU sedation
|
|
AU2005201500B2
(en)
|
1998-06-03 |
2007-01-04 |
Scott Laboratories, Inc. |
Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
|
|
AU750050B2
(en)
|
1998-06-03 |
2002-07-11 |
Scott Laboratories, Inc. |
Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
|
|
US7565905B2
(en)
|
1998-06-03 |
2009-07-28 |
Scott Laboratories, Inc. |
Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness
|
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
SK288117B6
(sk)
|
1998-11-20 |
2013-09-03 |
Skyepharma Canada Inc. |
Rapidly dispersing solid dry therapeutic dosage form
|
|
GB9901819D0
(en)
|
1999-01-27 |
1999-03-17 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
GB9908014D0
(en)
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
|
DE19940740A1
(de)
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
US6984207B1
(en)
|
1999-09-14 |
2006-01-10 |
Hoana Medical, Inc. |
Passive physiological monitoring (P2M) system
|
|
CA2324967A1
(en)
|
2000-11-01 |
2002-05-01 |
3816133 Canada Inc. |
System for monitoring patients with alzheimer's disease or related dementia
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
JP4323797B2
(ja)
|
2000-07-07 |
2009-09-02 |
エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス |
最適化した接着特性を有する親水性感圧接着剤の調製
|
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
US6814978B2
(en)
|
2000-12-29 |
2004-11-09 |
Mcneil-Ppc, Inc. |
Process for preparing a soft tablet
|
|
WO2002089794A1
(en)
|
2001-05-07 |
2002-11-14 |
Universite Catholique De Louvain |
Method for treating neuropathic pain and pharmaceutical preparation therefor
|
|
EP1397144A4
(en)
|
2001-05-15 |
2005-02-16 |
Psychogenics Inc |
SYSTEMS AND METHODS FOR MONITORING BEHAVIOR INFORMATION
|
|
US6509040B1
(en)
|
2001-06-22 |
2003-01-21 |
R.P. Scherer Corporation |
Fast dispersing dosage forms essentially free of mammalian gelatin
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US7425292B2
(en)
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
AU2002334939A1
(en)
|
2001-10-12 |
2003-04-22 |
Eugene R. Cooper |
Compositions having a combination of particles for immediate release and for controlled release
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US20140271788A1
(en)
|
2013-03-15 |
2014-09-18 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
FR2832311B1
(fr)
|
2001-11-21 |
2004-04-16 |
Besins Int Belgique |
Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
|
|
FR2834212B1
(fr)
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
EP1485296B1
(en)
|
2002-02-13 |
2011-07-20 |
Michael K. Weibel |
Drug dose - form and method of manufacture
|
|
WO2006031209A1
(en)
|
2003-05-28 |
2006-03-23 |
Monosolrx Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
DE60327335D1
(de)
|
2002-10-08 |
2009-06-04 |
Allergan Inc |
Alpha 2b oder 2b/2c adrenozeptor-agonisten zur behandlung von morbus alzheimer und morbus parkinson
|
|
US20040156894A1
(en)
|
2003-02-07 |
2004-08-12 |
Grother Leon Paul |
Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
|
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
|
US7470397B2
(en)
|
2003-10-24 |
2008-12-30 |
Adhesives Research, Inc. |
Disintegratable films for diagnostic devices
|
|
US9248146B2
(en)
|
2003-10-24 |
2016-02-02 |
Adhesives Research, Inc. |
Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
|
|
GB0403808D0
(en)
|
2004-02-20 |
2004-03-24 |
Bioprogress Technology Ltd |
Films for use as dosage forms
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
US7972621B2
(en)
|
2004-06-03 |
2011-07-05 |
R.P. Scherer Technologies, Llc |
Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
|
|
US20060058590A1
(en)
|
2004-08-24 |
2006-03-16 |
Shaw Geoffrey M |
Method and system for assaying agitation
|
|
US20060058700A1
(en)
|
2004-08-26 |
2006-03-16 |
Marro Dominic P |
Patient sedation monitor
|
|
CA2580694A1
(en)
|
2004-09-23 |
2006-03-30 |
Alexander Michalow |
Methods for regulating neurotransmitter systems by inducing counteradaptations
|
|
CA2599148A1
(en)
|
2005-02-22 |
2006-08-31 |
Health-Smart Limited |
Methods and systems for physiological and psycho-physiological monitoring and uses thereof
|
|
JP2008531714A
(ja)
|
2005-03-04 |
2008-08-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
不安障害の治療用及び／又は予防用の医薬組成物
|
|
US20090076156A1
(en)
|
2005-07-18 |
2009-03-19 |
Masud Husain |
Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
|
|
US20070106126A1
(en)
|
2005-09-30 |
2007-05-10 |
Mannheimer Paul D |
Patient monitoring alarm escalation system and method
|
|
WO2007041697A2
(en)
|
2005-10-04 |
2007-04-12 |
Medivation, Inc. |
Hydrogenated pyrido-indole compounds for the treatment of huntington ' s disease
|
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
JP2009521523A
(ja)
|
2005-12-27 |
2009-06-04 |
ジュビラント・オルガノシス・リミテッド |
口中溶解性医薬組成物およびその製造方法
|
|
PT1986642E
(pt)
|
2006-02-13 |
2014-01-30 |
Orient Pharma Samoa Co Ltd |
Combinação de agonista do receptor alfa-2 (clonidina) e um agente antimuscarínico (oxibutinina) para o tratamento de sialorreia
|
|
US7630758B2
(en)
|
2006-06-22 |
2009-12-08 |
General Electric Company |
Separation of natural and drug-induced sleep of a subject
|
|
US20080026040A1
(en)
|
2006-07-31 |
2008-01-31 |
Isaac Farr |
Active agent-releasing dosage forms
|
|
EP2063864A4
(en)
|
2006-09-20 |
2012-03-14 |
Monosol Rx Llc |
EDIBLE WATER-SOLUBLE FILM CONTAINING FLAVOR-REDUCING AGENT
|
|
US8157730B2
(en)
|
2006-12-19 |
2012-04-17 |
Valencell, Inc. |
Physiological and environmental monitoring systems and methods
|
|
US20080153808A1
(en)
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Alpha-2 receptor pan agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
|
|
WO2008091592A1
(en)
|
2007-01-22 |
2008-07-31 |
Targacept, Inc. |
Intranasal, buccal, and sublingual administration of metanicotine analogs
|
|
US8568777B2
(en)
|
2007-03-30 |
2013-10-29 |
Monosol Rx, Llc |
Packaged film dosage unit containing a complexate
|
|
CN101801346A
(zh)
|
2007-05-10 |
2010-08-11 |
诺瓦德尔药品公司 |
抗失眠症组合物及方法
|
|
WO2008153754A1
(en)
|
2007-05-24 |
2008-12-18 |
Peter Salgo |
System and method for patient monitoring
|
|
CN101686942B
(zh)
|
2007-06-27 |
2012-09-26 |
韩美药品株式会社 |
用于快速制备用于口服的崩解剂的方法及其产品
|
|
RU2338533C1
(ru)
|
2007-06-28 |
2008-11-20 |
Сергей Олегович Бачурин |
СРЕДСТВО, ОБЛАДАЮЩЕЕ АНКСИОЛИТИЧЕСКИМ ДЕЙСТВИЕМ, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
|
|
WO2009017836A1
(en)
|
2007-08-01 |
2009-02-05 |
Medivation Neurology, Inc. |
Methods and compositions for treating schizophrenia using antipsychotic combination therapy
|
|
WO2009048522A1
(en)
|
2007-10-11 |
2009-04-16 |
Richard Fuisz |
Smokeless tobacco product
|
|
US8298583B2
(en)
|
2007-10-19 |
2012-10-30 |
Monosol Rx, Llc |
Film delivery system for tetrahydrolipstatin
|
|
PE20091084A1
(es)
|
2007-12-07 |
2009-07-23 |
Schering Plough Healthcare |
Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
|
|
CN101496801A
(zh)
|
2008-02-02 |
2009-08-05 |
四川百利药业有限责任公司 |
右旋美托咪定及其药用盐的用途
|
|
PT2252290T
(pt)
|
2008-02-15 |
2018-02-14 |
Bone Therapeutics Sa |
Composição farmacêutica para utilização no tratamento e/ou prevenção de doenças osteoarticulares
|
|
MX2010009493A
(es)
|
2008-02-28 |
2010-12-20 |
Rp Scherer Technologies Llc |
Proceso para minimizar el polimorfismo.
|
|
US20190216389A1
(en)
|
2008-04-07 |
2019-07-18 |
Christopher Scheib |
Method and system for analyzing a series of electroencephalogram (eeg) signals during altered brain states
|
|
US20090275853A1
(en)
|
2008-04-30 |
2009-11-05 |
The General Electric Company |
Method and apparatus for monitoring physiological state of a subject
|
|
US8882684B2
(en)
|
2008-05-12 |
2014-11-11 |
Earlysense Ltd. |
Monitoring, predicting and treating clinical episodes
|
|
WO2010014758A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Pharmaceuticals, Inc. |
Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
|
|
WO2010031054A1
(en)
|
2008-09-15 |
2010-03-18 |
Biovista, Inc. |
Compositions and methods for treating epilepsy
|
|
US8485861B2
(en)
|
2008-10-31 |
2013-07-16 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
|
US8788212B2
(en)
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
|
US8470546B2
(en)
|
2008-11-25 |
2013-06-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Treatment of autism spectrum disorders with agents that activate the Locus Coeruleus-Noradrenergic system
|
|
US20100196286A1
(en)
|
2008-12-01 |
2010-08-05 |
Armer Thomas A |
Inhalation delivery methods and devices
|
|
US8282954B2
(en)
|
2008-12-15 |
2012-10-09 |
Monosol Rx, Llc |
Method for manufacturing edible film
|
|
TR200903014A1
(tr)
|
2009-04-17 |
2010-11-22 |
Sanovel İlaç San. Ve Ti̇c. A.Ş. |
Oral yolla dağılan dimebolin bileşimleri.
|
|
RU2572692C2
(ru)
|
2009-05-15 |
2016-01-20 |
Рекро Фарма, Инк. |
Сублингвальные композиции дексмедетомидина и способы их применения
|
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
|
US9775819B2
(en)
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
|
WO2011039686A1
(en)
|
2009-09-30 |
2011-04-07 |
Pfizer Inc. |
Latrepirdine oral sustained release dosage forms
|
|
AU2011204315A1
(en)
|
2010-01-08 |
2012-08-02 |
Recro Pharma, Inc. |
Topical transdermal dexmedetomidine compositions and methods of use thereof
|
|
US20110245633A1
(en)
|
2010-03-04 |
2011-10-06 |
Neumitra LLC |
Devices and methods for treating psychological disorders
|
|
US10548839B2
(en)
|
2010-03-16 |
2020-02-04 |
Wei Tian |
Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
|
|
US20130029989A1
(en)
|
2010-04-15 |
2013-01-31 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Topical treatments for pain
|
|
US9572773B2
(en)
|
2010-04-26 |
2017-02-21 |
Novartis A.G. |
Layered drug delivery device
|
|
US20110290694A1
(en)
|
2010-05-27 |
2011-12-01 |
Monosol Rx, Llc |
Oral film dosage form having indicia thereon
|
|
US8529914B2
(en)
|
2010-06-28 |
2013-09-10 |
Richard C. Fuisz |
Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
|
|
WO2012024106A2
(en)
|
2010-08-17 |
2012-02-23 |
University Of Florida Research Foundation, Inc. |
Central site photoplethysmography, medication administration, and safety
|
|
KR101802553B1
(ko)
|
2010-09-23 |
2017-11-28 |
모노졸 알엑스, 엘엘씨 |
제약 생성물을 패키지 표면 상에 직접적으로 형성시키는 방법 및 시스템
|
|
US8383135B2
(en)
|
2010-12-03 |
2013-02-26 |
Richard C. Fuisz |
Solid dosage form that promotes reliable oral, esophageal and GI transit
|
|
NZ612686A
(en)
|
2010-12-16 |
2015-11-27 |
Cynapsus Therapeutics Inc |
Sublingual films
|
|
US20140163080A1
(en)
|
2011-02-03 |
2014-06-12 |
Gnt, Llc |
Compositions and Methods for Treatment of Glaucoma
|
|
US8445526B2
(en)
|
2011-02-03 |
2013-05-21 |
Glaucoma & Nasal Therapies Llc |
Compositions and methods for treatment of glaucoma
|
|
WO2012104834A1
(en)
|
2011-02-03 |
2012-08-09 |
Pharmedica Ltd. |
New oral dissolving films for insulin administration, for treating diabetes
|
|
WO2016029227A1
(en)
|
2014-08-22 |
2016-02-25 |
The General Hospital Corporation |
Systems and methods for predicting arousal to consciousness during general anesthesia and sedation
|
|
US8241661B1
(en)
|
2011-06-24 |
2012-08-14 |
Fuisz Richard C |
Biocompatible film with variable cross-sectional properties
|
|
US8703697B2
(en)
|
2011-06-24 |
2014-04-22 |
Luc QUINTIN |
Method for treating early severe diffuse acute respiratory distress syndrome
|
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
|
US20130116215A1
(en)
|
2011-10-28 |
2013-05-09 |
Mireia Coma |
Combination therapies for treating neurological disorders
|
|
AU2012352528B9
(en)
|
2011-12-11 |
2017-11-02 |
Baudax Bio, Inc. |
Intranasal dexmedetomidine compositions and methods of use thereof
|
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
|
CA2865593A1
(en)
|
2012-02-27 |
2013-09-06 |
Eye Therapies Llc |
Compositions and methods for the treatment of migraine
|
|
JP5921928B2
(ja)
|
2012-03-28 |
2016-05-24 |
テルモ株式会社 |
既希釈デクスメデトミジン製剤
|
|
CN102657635B
(zh)
|
2012-05-04 |
2013-08-07 |
上海现代药物制剂工程研究中心有限公司 |
具有微孔的海绵状的阿塞那平舌下膜剂及其制备方法
|
|
WO2013173317A1
(en)
|
2012-05-14 |
2013-11-21 |
Prospire, Llc |
TREATMENT OF OBSTRUCTIVE SLEEP APNEA WITH α2-ADRENERGIC RECEPTOR AGONISTS
|
|
AU2013285988A1
(en)
|
2012-07-06 |
2015-02-12 |
Egalet Ltd. |
Abuse deterrent pharmaceutical compositions for controlled release
|
|
US10130766B1
(en)
|
2012-08-08 |
2018-11-20 |
Neurowave Systems Inc. |
Intelligent pharmaceutical delivery system with automatic shutoff and method of using
|
|
ES2536836T3
(es)
|
2012-10-12 |
2015-05-29 |
Omya International Ag |
Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
|
|
US20140180160A1
(en)
|
2012-10-12 |
2014-06-26 |
Emery N. Brown |
System and method for monitoring and controlling a state of a patient during and after administration of anesthetic compound
|
|
DK2906213T3
(en)
*
|
2012-10-15 |
2018-02-19 |
Orion Corp |
VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY
|
|
GB2510321B
(en)
|
2012-11-12 |
2018-01-31 |
Biosurgical S L |
Agitation apparatus
|
|
WO2014116770A1
(en)
|
2013-01-23 |
2014-07-31 |
Arx, Llc |
Production of unit dose constructs
|
|
EP2964270A4
(en)
|
2013-02-21 |
2017-03-22 |
University Of Rochester |
Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon
|
|
US9303918B2
(en)
|
2013-03-15 |
2016-04-05 |
Monosol Rx, Llc |
Process for drying a wet film with control of loss on drying
|
|
WO2014144365A1
(en)
|
2013-03-15 |
2014-09-18 |
University Of Maryland, College Park |
Nano-liposomal formulations and methods of use
|
|
US9346601B2
(en)
|
2013-03-15 |
2016-05-24 |
Monosol Rx, Llc |
Reduction in stress cracking of films
|
|
US20140261990A1
(en)
|
2013-03-15 |
2014-09-18 |
Monosol Rx, Llc |
Multi-layer films having uniform content
|
|
SG11201507898UA
(en)
|
2013-03-22 |
2015-11-27 |
Adhesives Res Inc |
Hydrophilic adhesives and tapes and devices containing the same
|
|
WO2014176356A1
(en)
|
2013-04-23 |
2014-10-30 |
The General Hospital Corporation |
System and method for monitoring anesthesia and sedation using measures of brain coherence and synchrony
|
|
WO2014176444A1
(en)
|
2013-04-24 |
2014-10-30 |
The General Hospital Corporation |
System and method for estimating high time-frequency resolution eeg spectrograms to monitor patient state
|
|
WO2014176441A1
(en)
|
2013-04-24 |
2014-10-30 |
The General Hospital Corporation |
System and method for monitoring level of dexmedatomidine-induced sedation
|
|
CN103284945A
(zh)
|
2013-06-03 |
2013-09-11 |
四川百利药业有限责任公司 |
一种预充式盐酸右美托咪定注射液的制备方法
|
|
HK1222404A1
(zh)
|
2013-06-04 |
2017-06-30 |
蒙诺苏尔有限公司 |
水溶性膜密封溶液、相关方法和相关物品
|
|
JP6660878B2
(ja)
|
2013-06-27 |
2020-03-11 |
ザ ジェネラル ホスピタル コーポレイション |
生理学的データにおける動的構造を追跡するためのシステムおよび該システムの作動方法
|
|
US10383574B2
(en)
|
2013-06-28 |
2019-08-20 |
The General Hospital Corporation |
Systems and methods to infer brain state during burst suppression
|
|
US10602978B2
(en)
|
2013-09-13 |
2020-03-31 |
The General Hospital Corporation |
Systems and methods for improved brain monitoring during general anesthesia and sedation
|
|
EP3054931B1
(en)
|
2013-10-07 |
2020-12-23 |
Teikoku Pharma USA, Inc. |
Transdermal delivery device for managing pain comprising dexmedetomidine transdermal compositions
|
|
CA2924233C
(en)
|
2013-10-07 |
2018-10-23 |
Teikoku Pharma Usa, Inc. |
Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
|
|
BR112016006848A2
(pt)
|
2013-10-07 |
2017-08-01 |
Teikoku Pharma Usa Inc |
métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
|
|
CA2924190C
(en)
|
2013-10-07 |
2019-07-09 |
Teikoku Pharma Usa, Inc. |
Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
|
|
KR101827980B1
(ko)
|
2013-10-07 |
2018-02-13 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
|
|
WO2015069778A1
(en)
|
2013-11-05 |
2015-05-14 |
The General Hospital Corporation |
System and method for determining neural states from physiological measurements
|
|
US11033493B2
(en)
|
2013-12-02 |
2021-06-15 |
Intelgenx Corp. |
Film dosage form with extended release mucoadhesive particles
|
|
US9974754B2
(en)
|
2013-12-18 |
2018-05-22 |
Maruishi Pharmaceutical Co., Ltd. |
Hydrous adhesive patch
|
|
WO2016029211A1
(en)
|
2014-08-22 |
2016-02-25 |
The General Hospital Corporation |
Systems and methods for discovery and characterization of neuroactive drugs
|
|
US20170274174A1
(en)
|
2014-08-22 |
2017-09-28 |
The General Hospital Corporation |
System and method for administering, monitoring and controlling biomimetic sleep
|
|
US9726337B2
(en)
*
|
2014-08-27 |
2017-08-08 |
R. W. Swarens Associates, Inc. |
Light fixture for indirect asymmetric illumination with LEDs
|
|
CN104161760A
(zh)
|
2014-09-01 |
2014-11-26 |
西北农林科技大学 |
一种貉用复合麻醉剂及其制备方法和应用
|
|
MA41689A
(fr)
*
|
2014-10-15 |
2017-08-22 |
Bioxcel Corp |
Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine
|
|
WO2016061554A1
(en)
*
|
2014-10-16 |
2016-04-21 |
Bioxcel Corporation |
Synergistic composition of known, safe pharmaceuticals for use in insomnia and a method of treatment thereof
|
|
FI127534B
(en)
|
2014-11-10 |
2018-08-31 |
Vetcare Oy |
Substituted benzoefuroquinolizine and ɑ2-adrenergic agonist comprising compositions
|
|
WO2016089997A1
(en)
|
2014-12-02 |
2016-06-09 |
Yale University |
Methods of preventing neurodegeneration of association cortex in a mammal
|
|
JP2016154598A
(ja)
|
2015-02-23 |
2016-09-01 |
ニプロ株式会社 |
デクスメデトミジン注射液を充填したプレフィルドシリンジ
|
|
CN104784174A
(zh)
|
2015-03-06 |
2015-07-22 |
北京大学第一医院 |
右美托咪定的药物新用途
|
|
CN107683140A
(zh)
|
2015-04-10 |
2018-02-09 |
特丽珂生物医学股份有限公司 |
用于控制出血和用于促进治愈的生物粘附性脱乙酰壳多糖凝胶，其减少疤痕而不模糊或干扰术野的获得
|
|
CN106038538A
(zh)
|
2015-04-17 |
2016-10-26 |
江苏恒瑞医药股份有限公司 |
一种右美托咪定的预混合制剂
|
|
US10179136B2
(en)
|
2015-06-19 |
2019-01-15 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for anesthesiological applications
|
|
US20160374588A1
(en)
|
2015-06-24 |
2016-12-29 |
Microsoft Technology Licensing, Llc |
Monitoring hydration based on galvanic skin response
|
|
CN105168122B
(zh)
|
2015-09-24 |
2018-11-27 |
辰欣药业股份有限公司 |
一种盐酸右美托咪定注射液及其制备工艺
|
|
US20170128421A1
(en)
|
2015-11-11 |
2017-05-11 |
Siva Prasad Reddy Sura |
Premix formulation for parenteral use and packaging thereof
|
|
US10632043B2
(en)
|
2015-11-11 |
2020-04-28 |
Aurobindo Pharma Ltd |
Premix formulation for parenteral use and packaging thereof
|
|
WO2017117627A1
(en)
|
2016-01-04 |
2017-07-13 |
Jurox Pty Ltd |
Drug release device and use
|
|
CN105534891A
(zh)
|
2016-01-18 |
2016-05-04 |
南京正科医药股份有限公司 |
一种盐酸右美托咪定注射液
|
|
US9949934B1
(en)
|
2016-10-20 |
2018-04-24 |
Intelgenx Corp. |
Device and method of treating conditions associated with neuroinflammation
|
|
US9717796B1
(en)
|
2016-04-20 |
2017-08-01 |
Slypharma, Llc |
Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
|
|
CN107412152B
(zh)
|
2016-05-24 |
2020-12-04 |
海南合瑞制药股份有限公司 |
一种盐酸右美托咪定注射液组合物
|
|
CA3026783A1
(en)
|
2016-06-07 |
2017-12-14 |
Akhil MEHRA |
Methods and compositions for the treatment of trauma and stressor-related disorders
|
|
CN105997955B
(zh)
|
2016-06-28 |
2017-09-12 |
力品药业（厦门）有限公司 |
一种帕洛诺司琼口腔膜剂及其制备方法
|
|
RU2635532C1
(ru)
|
2016-09-06 |
2017-11-13 |
Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации |
Способ профилактики ажитационного синдрома у детей с онкологической патологией
|
|
CN110114119B
(zh)
|
2016-10-12 |
2022-05-31 |
Ps治疗有限公司 |
人工泪液、隐形眼镜和药物载体组合物及其使用方法
|
|
CA3040422A1
(en)
|
2016-10-13 |
2018-04-19 |
Catalent U.K. Swindon Zydis Limited |
Lyophilized pharmaceutical compositions for vaginal delivery
|
|
JP6968184B2
(ja)
|
2016-10-25 |
2021-11-17 |
キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド |
速崩壊多層錠のための異なる密度の組成物
|
|
TWI764951B
(zh)
|
2016-10-31 |
2022-05-21 |
美商帝國製藥美國股份有限公司 |
用於處理疼痛之右美托咪啶經皮遞送裝置
|
|
US20180147201A1
(en)
|
2016-10-31 |
2018-05-31 |
Allodynic Therapeutics, Llc |
Combinations of opioid/tlr4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
|
|
CN106727524A
(zh)
|
2016-11-08 |
2017-05-31 |
叶茂 |
一种药物组合物及其应用
|
|
CN106539778A
(zh)
|
2016-12-08 |
2017-03-29 |
武汉大学 |
一种小儿麻醉术前含服口腔泡腾片及其制备方法
|
|
CN106727443A
(zh)
|
2016-12-08 |
2017-05-31 |
武汉大学 |
一种小儿麻醉术前镇静的隐形鼻贴制剂及其制备方法
|
|
SI3554501T1
(sl)
|
2016-12-13 |
2021-09-30 |
Orion Corporation |
Deksmedetomidin ali medetomidin za uporabo pri zdravljenju ločitvene tesnobe pri hišnih živalih
|
|
WO2018116202A1
(en)
|
2016-12-20 |
2018-06-28 |
Azista Industries Pvt Ltd |
Stabilized mouth freshener strips
|
|
KR102793584B1
(ko)
|
2016-12-31 |
2025-04-09 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
불안의 치료를 위한 설하 덱스메데토미딘의 용도
|
|
WO2018162845A1
(fr)
|
2017-03-07 |
2018-09-13 |
CHILDS, Marc |
Prevention des risques associes à un allongement de l'intervalle qt d'origine medicamenteuse à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale
|
|
CN107693485A
(zh)
|
2017-04-24 |
2018-02-16 |
重庆医科大学附属儿童医院 |
一种用于麻醉的滴鼻液及其制备方法
|
|
CN107412204A
(zh)
|
2017-04-24 |
2017-12-01 |
重庆医科大学附属儿童医院 |
一种用于麻醉的干粉吸入剂及其制备方法
|
|
CN107137399A
(zh)
|
2017-04-24 |
2017-09-08 |
徐颖 |
一种用于麻醉的舌下片及其制备方法
|
|
CN107028880A
(zh)
|
2017-06-09 |
2017-08-11 |
安徽赛诺制药有限公司 |
一种盐酸右美托咪定注射液的生产工艺
|
|
EP3668488A4
(en)
|
2017-08-15 |
2021-03-24 |
The Board of Trustees of the Leland Stanford Junior University |
POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR THE ULTRASONIC TREATMENT OF MEDICINAL PRODUCTS
|
|
US11331270B2
(en)
|
2017-08-20 |
2022-05-17 |
Nasus Pharma Ltd. |
Dry powder compositions for intranasal delivery
|
|
US11857334B2
(en)
|
2017-10-04 |
2024-01-02 |
The General Hospital Corporation |
Systems and methods for monitoring a subject under the influence of drugs
|
|
US20190216345A1
(en)
|
2017-10-18 |
2019-07-18 |
Christoper Scheib |
Method and system for monitoring and displaying physiological conditions
|
|
US11147459B2
(en)
|
2018-01-05 |
2021-10-19 |
CareBand Inc. |
Wearable electronic device and system for tracking location and identifying changes in salient indicators of patient health
|
|
US11406316B2
(en)
|
2018-02-14 |
2022-08-09 |
Cerenion Oy |
Apparatus and method for electroencephalographic measurement
|
|
IL277009B2
(en)
|
2018-03-08 |
2024-06-01 |
Catalent Uk Swindon Zydis Ltd |
Process to reduce endotoxin in gelatin
|
|
KR20190109310A
(ko)
|
2018-03-15 |
2019-09-25 |
주식회사 바이오홀딩스 |
레반을 함유하는 염증성 질환 치료용 경비투여형 스프레이 제제
|
|
CN108498469A
(zh)
|
2018-05-30 |
2018-09-07 |
宁波蒙曼生物科技有限公司 |
盐酸右美托咪定冻干粉及其制备方法
|
|
WO2020006119A1
(en)
|
2018-06-27 |
2020-01-02 |
Bioxcel Therapeutics, Inc. |
Methods for treating agitation using dexmedetomidine hydrochloride
|
|
PL3813802T3
(pl)
|
2018-06-27 |
2025-04-22 |
Bioxcel Therapeutics, Inc. |
Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania
|
|
US11648197B2
(en)
|
2018-06-28 |
2023-05-16 |
Arx, Llc |
Dispensing method for producing dissolvable unit dose film constructs
|
|
CN110893186A
(zh)
|
2018-09-12 |
2020-03-20 |
宜昌人福药业有限责任公司 |
一种药物组合物及其制备方法和用途
|
|
JP2019048091A
(ja)
|
2018-10-23 |
2019-03-28 |
ニプロ株式会社 |
デクスメデトミジン注射液を充填したプレフィルドシリンジ
|
|
KR102183744B1
(ko)
|
2018-11-26 |
2020-11-27 |
연세대학교 산학협력단 |
섬망 발병 위험도의 예측 방법 및 이를 이용한 디바이스
|
|
CN109620802A
(zh)
|
2018-12-05 |
2019-04-16 |
杜皓 |
一种麻醉用鼻喷剂及其制备方法
|
|
CN111481506B
(zh)
|
2019-01-25 |
2023-01-24 |
江苏恒瑞医药股份有限公司 |
一种包含经鼻给药的右美托咪定组合物的药物制品
|
|
US10900762B2
(en)
|
2019-02-21 |
2021-01-26 |
Aob Products Company |
Ammunition press and components thereof
|
|
CN112107544A
(zh)
|
2019-06-28 |
2020-12-22 |
四川普锐特药业有限公司 |
右美托咪定鼻喷剂、其制备方法及应用
|
|
CN116474219A
(zh)
|
2019-06-28 |
2023-07-25 |
四川普锐特药业有限公司 |
保持给药均一度的药物流体分配器及右美托咪定鼻喷器
|
|
EP3999058A4
(en)
|
2019-07-19 |
2023-05-03 |
Bioxcel Therapeutics, Inc. |
NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN
|
|
EP4031000A4
(en)
|
2019-09-18 |
2023-09-27 |
Bioxcel Therapeutics, Inc. |
Systems and methods for detection and prevention of emergence of agitation
|
|
IL295489A
(en)
|
2020-02-14 |
2022-10-01 |
Bioxcel Therapeutics Inc |
Systems and methods for detecting and preventing the onset of restlessness
|
|
EP4225305A4
(en)
|
2020-10-08 |
2024-10-23 |
Bioxcel Therapeutics, Inc. |
TREATMENT OF BIPOLAR DISEASES AND PSYCHOSES WITH DEXMEDETOMIDINE HYDROCHLORIDE
|
|
WO2022147537A1
(en)
|
2021-01-04 |
2022-07-07 |
Bioxcel Therapeutics, Inc. |
Dexmedetomidine treatment regimens
|
|
TW202302094A
(zh)
|
2021-02-26 |
2023-01-16 |
美商百歐克斯賽爾治療公司 |
用於治療激躁之方法及組合物
|